| USD ($) $ in Millions | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | |||||||||||||||||||||||
Net income including non-controlling interests | $ 2,416 | $ 282 | $ 6,652 | $ 1,350 | $ 1,774 | $ 2,599 | $ 1,008 | $ (663) | $ 219 | $ 394 | $ (157) | $ (1,204) | |||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||||||
Depreciation and amortization | 195 | 191 | 195 | 181 | 178 | 186 | 181 | 194 | 205 | 208 | 207 | 227 | |||||||||||
Bad debt expense | - | - | - | - | - | 12 | 9 | 26 | 19 | 24 | 20 | 25 | |||||||||||
Stock-based compensation | 550 | 473 | 465 | 475 | 435 | 438 | 455 | 484 | 492 | 504 | 470 | 482 | |||||||||||
Gain on extinguishment of convertible notes and settlement of derivatives | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Gain on business divestitures | - | - | - | - | - | - | - | - | 0 | - | - | (14) | |||||||||||
Gain from sale of investments | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Deferred income taxes | 665 | 106 | (4,167) | 87 | (412) | 124 | (7) | (16) | 16 | 6 | 10 | 16 | |||||||||||
(Gains) losses on debt and equity securities, net | (1,612) | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
(Gains) losses on foreign currency transactions, net | (53) | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Revaluation of derivative liabilities | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Accretion of discount on long-term debt | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Payment-in-kind interest | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Loss on disposal of property and equipment | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Impairment on long-lived assets held for sale | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Loss (income) from equity method investments, net | - | - | - | - | - | 12 | 12 | 4 | (3) | (4) | (36) | (30) | |||||||||||
Unrealized (gain) loss on debt and equity securities, net | - | 1,474 | (1,471) | 17 | (51) | (1,664) | (333) | 721 | 96 | (386) | (320) | 550 | |||||||||||
Loss from sale of investment | - | - | - | - | - | - | - | - | - | 74 | - | - | |||||||||||
Impairment of debt and equity securities | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Impairments of goodwill, long-lived assets and other assets | - | - | - | - | - | - | - | 0 | (1) | 11 | 67 | - | |||||||||||
Impairment of equity method investment | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||||||||
Revaluation of MLU B.V. call option | - | - | - | - | - | - | - | - | 0 | 0 | 0 | (10) | |||||||||||
Gain on debt and equity securities, net | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Non-cash deferred revenue | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Gain on extinguishment of warrant and call option | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Unrealized foreign currency transactions | - | 5 | 22 | (101) | (51) | (36) | 59 | 150 | 71 | 2 | 83 | 15 | |||||||||||
Other | 296 | 20 | (16) | 106 | (27) | (31) | (79) | (59) | (35) | 6 | 4 | 7 | |||||||||||
Change in assets and liabilities, net of impact of business acquisitions and disposals: | |||||||||||||||||||||||
Accounts receivable | (425) | (74) | (22) | (212) | (123) | 196 | (162) | (422) | (518) | (13) | 168 | (90) | |||||||||||
Prepaid expenses and other assets | (163) | (212) | (126) | (251) | (497) | (234) | (108) | (322) | (948) | (114) | (119) | (115) | |||||||||||
Collateral held by insurer | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Operating lease right-of-use assets | 38 | 62 | 46 | 46 | 43 | 44 | 47 | 46 | 47 | 42 | 52 | 47 | |||||||||||
Accounts payable | 161 | 184 | 101 | 125 | 6 | 48 | (70) | 46 | 112 | (19) | (7) | (35) | |||||||||||
Accrued insurance reserves | 387 | 443 | 592 | 812 | 675 | 776 | 692 | 693 | 501 | 588 | 350 | 159 | |||||||||||
Accrued expenses and other liabilities | 447 | (541) | 111 | (20) | 430 | (243) | 141 | 590 | 740 | (87) | (142) | 483 | |||||||||||
Operating lease liabilities | (35) | (62) | (54) | (51) | (56) | (76) | (25) | (56) | (47) | (46) | (44) | (81) | |||||||||||
Net cash provided by operating activities | 2,862 | 2,351 | 2,328 | 2,564 | 2,324 | 2,151 | 1,820 | 1,416 | 966 | 1,190 | 606 | 432 | |||||||||||
Cash flows from investing activities | |||||||||||||||||||||||
Proceeds from sale and disposal of property and equipment | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Proceeds from insurance reimbursement, sale and disposal of property and equipment | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Purchases of property and equipment | (70) | (65) | (98) | (89) | (74) | (42) | (99) | (57) | (61) | (50) | (57) | (74) | |||||||||||
Purchases of marketable securities | (10,887) | (6,759) | (6,310) | (5,095) | (2,540) | (4,428) | (3,288) | (2,029) | (3,723) | (1,361) | (846) | - | |||||||||||
Purchases of non-marketable equity securities | (175) | (332) | (95) | (12) | (179) | (56) | (58) | (174) | (42) | - | 0 | - | |||||||||||
Purchases of notes receivable | (111) | (187) | - | - | - | - | - | - | - | - | - | - | |||||||||||
Proceeds from maturities and sales of marketable securities | 8,119 | 6,546 | 6,514 | 4,636 | 2,397 | 1,916 | 1,821 | 2,030 | 1,366 | 1,127 | 500 | 376 | |||||||||||
Proceeds from sale of non-marketable equity securities | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Purchase of equity method investments | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Proceeds from business disposals, net of cash divested | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Acquisition of businesses, net of cash acquired | (647) | (6) | - | (804) | - | - | - | - | - | - | 0 | - | |||||||||||
Purchase of total return swaps | (16) | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Proceeds from sale of equity method investment | - | - | - | - | - | - | 8 | 9 | 18 | 703 | - | - | |||||||||||
Proceeds from business divestiture | - | - | - | - | - | - | - | - | - | - | - | 26 | |||||||||||
Return of capital from equity method investee | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Other investing activities | 22 | 30 | 42 | (97) | (146) | (82) | (60) | (21) | 26 | (11) | 4 | (7) | |||||||||||
Net cash used in investing activities | (5,389) | (773) | 53 | (1,461) | (542) | (2,692) | (1,676) | (242) | (2,416) | 408 | (399) | 321 | |||||||||||
Cash flows from financing activities | |||||||||||||||||||||||
Proceeds from issuance of subsidiary preferred stock units | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Proceeds from term loan, notes, and credit facility, net of issuance costs | 3,997 | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Proceeds from issuance of common stock upon initial public offering, net of offering costs | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Taxes paid related to net share settlement of equity awards | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan | 136 | - | - | 120 | - | - | 103 | - | - | 85 | - | - | |||||||||||
Issuance of term loan and notes, net of issuance costs | - | - | 2,232 | 1,127 | - | 3,972 | - | 0 | - | - | 1,121 | - | |||||||||||
Proceeds from issuance of common stock related to private placement | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Proceeds from exercise of stock options, net of repurchases | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Repurchase of outstanding shares | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Principal repayment on term loan, notes, and credit facility | (2,000) | - | (1,200) | - | 0 | (1,973) | (7) | (6) | 1,150 | - | - | - | |||||||||||
Principal repayments on Careem Notes | - | - | - | - | - | - | - | - | 1,119 | (7) | (1,137) | - | |||||||||||
Principal repayment on revolving lines of credit | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Principal payments on finance leases | (42) | (40) | (37) | (28) | (47) | (45) | (35) | (42) | (36) | (42) | (40) | (39) | |||||||||||
Repurchases of common stock | (518) | (3,011) | (1,463) | (1,363) | (1,785) | (372) | (325) | - | - | - | - | - | |||||||||||
Proceeds from issuance and sale of subsidiary stock units | - | - | - | - | - | - | - | - | - | - | - | 255 | |||||||||||
Proceeds from sale of subsidiary preferred stock units | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Dissolution of joint venture and subsequent proceeds | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Other financing activities | (33) | (40) | (70) | (51) | (30) | 19 | 73 | (52) | (9) | 6 | (51) | (4) | |||||||||||
Net cash used in financing activities | 1,540 | (3,091) | (538) | (195) | (1,862) | 1,601 | (191) | (100) | (76) | 42 | (107) | 212 | |||||||||||
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents | 54 | (24) | (27) | 159 | 70 | 62 | (56) | (94) | (69) | 27 | 16 | (195) | |||||||||||
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents | (933) | (1,537) | 1,816 | 1,067 | (10) | 1,122 | (103) | 980 | (1,595) | 1,667 | 116 | 770 | |||||||||||
Cash and cash equivalents, and restricted cash and cash equivalents | |||||||||||||||||||||||
Reclassification from assets held for sale during the period | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Supplemental disclosures of cash flow information | |||||||||||||||||||||||
Cash paid for: | |||||||||||||||||||||||
Interest, net of amount capitalized | 20 | 180 | 186 | 13 | 174 | 139 | 118 | 142 | 157 | 155 | 157 | 137 | |||||||||||
Income taxes, net of refunds | 196 | 84 | 107 | 112 | 55 | 85 | 86 | 71 | 100 | 48 | 22 | 44 | |||||||||||
Non-cash investing and financing activities: | |||||||||||||||||||||||
Financed construction projects | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Settlement of litigation through issuance of redeemable convertible preferred stock | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Ownership interest in MLU B.V. received in connection with the disposition of Uber Russia/CIS operations | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Grab debt security received in exchange for the sale of Southeast Asia operations | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Changes in purchases of property, equipment and software recorded in accounts payable and accrued liabilities | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Finance lease obligations | - | - | - | - | - | 1 | - | 2 | 40 | 43 | 120 | 95 | |||||||||||
Common stock issued in connection with acquisitions | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Right-of-use assets obtained in exchange for lease obligations | 149 | 418 | - | - | - | 55 | 17 | 25 | 17 | 18 | 12 | (17) | |||||||||||
Ownership interest received in exchange for divestiture | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Conversion of redeemable convertible preferred stock to common stock upon initial public offering | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Conversion of convertible notes to common stock | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Issuance of Careem Notes including the holdback amount | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Holdback amount of unsecured convertible notes in connection with Careem acquisition | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||
Reclassification of marketable securities to equity method investments | $ 2,517 | - | - | - | - | - | - | - | - | - | - | - |